Researchers at The University of Pennsylvania College of Medicine in Hershey sought to determine the attributable costs and LOS associated with CLABSIs in the pediatric hematology and oncology population.
They examined 1,562 inpatient admissions for 291 pediatric patients between January 2008 and May 2011.
The study demonstrated the additional LOS related to a CLABSI in this population was 21.2 days, and increased costs of nearly $70,000.
They suggest their findings could help shape decisions about efforts to prevent CLABSIs for pediatric oncology patients.
More articles on HAIs:
10 most popular infection control stories for October
4 areas to focus on for improved hand hygiene
Topical antibiotics linked to increased pneumonia rates
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
